CCM
IONS icon

Covington Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Covington Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23
Closed -$1K – 1032
2021
Q3 		$1K Sell
23
-13
-36% -$490 ﹤0.01% 986
2021
Q2 		$1K Buy
+36
New +$1.41K ﹤0.01% 922
2018
Q1 		– Sell
-175
Closed -$9K – 750
2017
Q4 		$9K Hold
175
– – ﹤0.01% 682
2017
Q3 		$9K Buy
+175
New +$9.17K ﹤0.01% 623

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Covington Capital Management's IONS Position: Q4 2021 in Review

Covington Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 23 shares — an estimated $1K sold.

Covington Capital Management first reported a position in IONS in Q3 2017 and held it in 4 quarters. The position peaked at $9K in Q4 2017. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • Covington Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Covington Capital Management sold 23 Ionis Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Covington Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • Covington Capital Management's Ionis Pharmaceuticals position peaked at $9K in Q4 2017.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Covington Capital Management's 13F filing for Q4 2021, filed 16 Feb 2022.